AD
NASDAQ · ADXN
Addex Therapeutics Ltd
Healthcare · Biotechnology
$3.22
Up+$0.04 (+1.21%)
Updated Oct 10, 2026, 6:42 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.81M
- P/E ratio
- -0.89
- Dividend yield
- 0.00%
- 52-week range
- $2.56 – $7.60
- Volume
- 4.51K
- Avg. volume
- 6.27K
Price performance · ADXN
ADXN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
ADXN closed at $3.22 after 21 trading sessions, down 7.78% for the selected period.
- Last close
- $3.22
- Period change
- -7.78%
- Period low
- $2.76
- Period high
- $3.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $3.09 | $3.249 | $3.09 | $3.2186 | 4.51K |
| Oct 8, 2026 | $3.22 | $3.23 | $3.00 | $3.18 | 11.68K |
| Oct 7, 2026 | $3.1454 | $3.16 | $2.9773 | $3.13 | 9.4K |
| Oct 6, 2026 | $3.1492 | $3.205 | $3.14 | $3.18 | 1.75K |
| Oct 5, 2026 | $3.11 | $3.13 | $3.10 | $3.10 | 5.9K |
| Oct 2, 2026 | $3.01 | $3.08 | $2.99 | $3.07 | 13.41K |
| Oct 1, 2026 | $2.83 | $2.98 | $2.7842 | $2.98 | 6.91K |
| Sep 30, 2026 | $2.91 | $2.91 | $2.67 | $2.76 | 5.25K |
| Sep 29, 2026 | $2.74 | $2.97 | $2.69 | $2.95 | 31.35K |
| Sep 28, 2026 | $3.69 | $3.74 | $2.56 | $2.81 | 90.66K |
| Sep 25, 2026 | $3.62 | $3.80 | $3.52 | $3.65 | 15.48K |
| Sep 24, 2026 | $3.45 | $3.60 | $3.40 | $3.46 | 7.87K |
| Sep 23, 2026 | $3.48 | $3.54 | $3.4209 | $3.45 | 12.95K |
| Sep 22, 2026 | $3.50 | $3.53 | $3.23 | $3.50 | 4.89K |
| Sep 21, 2026 | $3.35 | $3.53 | $3.3405 | $3.53 | 9.57K |
| Sep 18, 2026 | $3.3698 | $3.44 | $3.3698 | $3.40 | 3K |
| Sep 17, 2026 | $3.35 | $3.45 | $3.29 | $3.36 | 27.24K |
| Sep 16, 2026 | $3.29 | $3.44 | $3.22 | $3.36 | 40.31K |
| Sep 15, 2026 | $3.34 | $3.42 | $3.10 | $3.26 | 24.2K |
| Sep 14, 2026 | $3.3903 | $3.48 | $3.21 | $3.48 | 14.09K |
| Sep 11, 2026 | $3.49 | $3.6516 | $3.30 | $3.49 | 35.6K |
Latest ADXN news
The latest Smart Investors Daily articles mentioning ADXN.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…
